Abstract
Through a public County/University partnership, we employed a Spanish/English bilingual research coordinator to increase awareness of newly available treatments with FDA Emergency Use Authorization and clinical trial opportunities for Latino outpatients with mild to moderate COVID-19. Out of the 550 San Mateo County outpatients with COVID-19 referred to Stanford University between July 2020 and April 2022, 9.5% elected to receive monoclonal antibody EUA treatment. COVID-19 treatment trial enrollment of County patients, 5% of those recruited, was commensurate with non-County populations enrollment. Recruitment models such as ours have the potential to increase US Latino populations’ recruitment in outpatient COVID-19 treatment trials and contribute to decreasing COVID-19 health disparities.
【저자키워드】 COVID-19, recruitment, Latino, 【초록키워드】 Treatment, clinical trial, Trial, monoclonal antibody, FDA, EUA, Population, Moderate COVID-19, Health, Mild, patients, Outpatient, Emergency, Enrollment, authorization, Stanford University, recruited, contribute, receive, research coordinator, treatment trial, with COVID-19, 【제목키워드】 Trial, Clinical treatment, Spanish,